Peringatan Keamanan

The median lethal dose is higher than the maximum oral dose tested in mice and rats (1825 mg/kg per day). Overdoses up to 31,500 mg of atovaquone have been reported. In one such patient who also took an unspecified dose of dapsone, methemoglobinemia occurred. Rash has also been reported after overdose.

Atovaquone

DB01117

small molecule approved

Deskripsi

Atovaquone is a hydroxynaphthoquinone, or an analog of ubiquinone, that has antimicrobial and antipneumocystis activity. It is being used in antimalarial protocols.

Struktur Molekul 2D

Berat 366.837
Wujud solid

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) 2.2 to 3.2 days
Volume Distribusi * 0.60 ± 0.17 L/kg
Klirens (Clearance) * 10.4 +/- 5.5 ml/min [HIV-infected patients receiving IV administration]

Absorpsi

The bioavailability of atovaquone is low and variable and is highly dependent on formulation and diet. Bioavailability of the suspension increases two-fold when administered with meals. When administered with food, bioavailability is approximately 47%. Without food, the bioavailability is 23%.

Metabolisme

Some evidence suggests limited metabolism (although no metabolites have been identified).

Rute Eliminasi

The half-life of atovaquone is long due to presumed enterohepatic cycling and eventual fecal elimination. There was little or no excretion of atovaquone in the urine (less than 0.6%).

Interaksi Makanan

1 Data
  • 1. Take with food. Administration with a meal significantly enhances bioavailability.

Interaksi Obat

366 Data
Artemether The risk or severity of QTc prolongation can be increased when Atovaquone is combined with Artemether.
Lumefantrine The risk or severity of QTc prolongation can be increased when Atovaquone is combined with Lumefantrine.
Indinavir Atovaquone can cause a decrease in the absorption of Indinavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Ritonavir The serum concentration of Atovaquone can be decreased when it is combined with Ritonavir.
Efavirenz The serum concentration of Atovaquone can be decreased when it is combined with Efavirenz.
Tetracycline The serum concentration of Atovaquone can be decreased when it is combined with Tetracycline.
Etoposide The serum concentration of Etoposide can be increased when it is combined with Atovaquone.
Metoclopramide Metoclopramide can cause a decrease in the absorption of Atovaquone resulting in a reduced serum concentration and potentially a decrease in efficacy.
Thiethylperazine The risk or severity of QTc prolongation can be increased when Atovaquone is combined with Thiethylperazine.
Promazine The risk or severity of QTc prolongation can be increased when Atovaquone is combined with Promazine.
Prochlorperazine The risk or severity of QTc prolongation can be increased when Atovaquone is combined with Prochlorperazine.
Chlorpromazine The risk or severity of QTc prolongation can be increased when Atovaquone is combined with Chlorpromazine.
Triflupromazine The risk or severity of QTc prolongation can be increased when Atovaquone is combined with Triflupromazine.
Fluphenazine The risk or severity of QTc prolongation can be increased when Atovaquone is combined with Fluphenazine.
Thioridazine The risk or severity of QTc prolongation can be increased when Atovaquone is combined with Thioridazine.
Moricizine The risk or severity of QTc prolongation can be increased when Atovaquone is combined with Moricizine.
Trifluoperazine The risk or severity of QTc prolongation can be increased when Atovaquone is combined with Trifluoperazine.
Perphenazine The risk or severity of QTc prolongation can be increased when Atovaquone is combined with Perphenazine.
Mesoridazine The risk or severity of QTc prolongation can be increased when Atovaquone is combined with Mesoridazine.
Acetophenazine The risk or severity of QTc prolongation can be increased when Atovaquone is combined with Acetophenazine.
Promethazine The risk or severity of QTc prolongation can be increased when Atovaquone is combined with Promethazine.
Alimemazine The risk or severity of QTc prolongation can be increased when Atovaquone is combined with Alimemazine.
Methotrimeprazine The risk or severity of QTc prolongation can be increased when Atovaquone is combined with Methotrimeprazine.
Periciazine The risk or severity of QTc prolongation can be increased when Atovaquone is combined with Periciazine.
Acepromazine The risk or severity of QTc prolongation can be increased when Atovaquone is combined with Acepromazine.
Aceprometazine The risk or severity of QTc prolongation can be increased when Atovaquone is combined with Aceprometazine.
Pipotiazine The risk or severity of QTc prolongation can be increased when Atovaquone is combined with Pipotiazine.
Thioproperazine The risk or severity of QTc prolongation can be increased when Atovaquone is combined with Thioproperazine.
BL-1020 The risk or severity of QTc prolongation can be increased when Atovaquone is combined with BL-1020.
Cyamemazine The risk or severity of QTc prolongation can be increased when Atovaquone is combined with Cyamemazine.
Methylene blue The risk or severity of QTc prolongation can be increased when Atovaquone is combined with Methylene blue.
Propiopromazine The risk or severity of QTc prolongation can be increased when Atovaquone is combined with Propiopromazine.
Perazine The risk or severity of QTc prolongation can be increased when Atovaquone is combined with Perazine.
Butaperazine The risk or severity of QTc prolongation can be increased when Atovaquone is combined with Butaperazine.
Chlorproethazine The risk or severity of QTc prolongation can be increased when Atovaquone is combined with Chlorproethazine.
Thiazinam The risk or severity of QTc prolongation can be increased when Atovaquone is combined with Thiazinam.
Dixyrazine The risk or severity of QTc prolongation can be increased when Atovaquone is combined with Dixyrazine.
Perphenazine enanthate The risk or severity of QTc prolongation can be increased when Atovaquone is combined with Perphenazine enanthate.
Dapsone The risk or severity of adverse effects can be increased when Atovaquone is combined with Dapsone.
Vemurafenib The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Atovaquone.
Pitolisant The serum concentration of Atovaquone can be decreased when it is combined with Pitolisant.
Metreleptin The metabolism of Atovaquone can be increased when combined with Metreleptin.
Valsartan The metabolism of Valsartan can be decreased when combined with Atovaquone.
Bortezomib The metabolism of Bortezomib can be decreased when combined with Atovaquone.
Troglitazone The metabolism of Troglitazone can be decreased when combined with Atovaquone.
Torasemide The metabolism of Torasemide can be decreased when combined with Atovaquone.
Glimepiride The metabolism of Glimepiride can be decreased when combined with Atovaquone.
Desogestrel The metabolism of Desogestrel can be decreased when combined with Atovaquone.
Bexarotene The metabolism of Bexarotene can be decreased when combined with Atovaquone.
Hydromorphone The metabolism of Hydromorphone can be decreased when combined with Atovaquone.
Indomethacin The metabolism of Indomethacin can be decreased when combined with Atovaquone.
Methadone The metabolism of Methadone can be decreased when combined with Atovaquone.
Trimethadione The metabolism of Trimethadione can be decreased when combined with Atovaquone.
Treprostinil The metabolism of Treprostinil can be decreased when combined with Atovaquone.
Rosiglitazone The metabolism of Rosiglitazone can be decreased when combined with Atovaquone.
Acetohexamide The metabolism of Acetohexamide can be decreased when combined with Atovaquone.
Trimethoprim The metabolism of Trimethoprim can be decreased when combined with Atovaquone.
Nabumetone The metabolism of Nabumetone can be decreased when combined with Atovaquone.
Tenoxicam The metabolism of Tenoxicam can be decreased when combined with Atovaquone.
Dronabinol The serum concentration of Dronabinol can be increased when it is combined with Atovaquone.
Montelukast The metabolism of Montelukast can be decreased when combined with Atovaquone.
Fluoxetine The metabolism of Fluoxetine can be decreased when combined with Atovaquone.
Duloxetine The metabolism of Duloxetine can be decreased when combined with Atovaquone.
Celecoxib The metabolism of Celecoxib can be decreased when combined with Atovaquone.
Zidovudine The metabolism of Zidovudine can be decreased when combined with Atovaquone.
Dextromethorphan The metabolism of Dextromethorphan can be decreased when combined with Atovaquone.
Mephenytoin The metabolism of Mephenytoin can be decreased when combined with Atovaquone.
Rofecoxib The metabolism of Rofecoxib can be decreased when combined with Atovaquone.
Zafirlukast The metabolism of Zafirlukast can be decreased when combined with Atovaquone.
Piroxicam The metabolism of Piroxicam can be decreased when combined with Atovaquone.
Bosentan The metabolism of Bosentan can be decreased when combined with Atovaquone.
Cinnarizine The metabolism of Cinnarizine can be decreased when combined with Atovaquone.
Valdecoxib The metabolism of Valdecoxib can be decreased when combined with Atovaquone.
Diclofenac The metabolism of Diclofenac can be decreased when combined with Atovaquone.
Doxazosin The metabolism of Doxazosin can be decreased when combined with Atovaquone.
Paramethadione The metabolism of Paramethadione can be decreased when combined with Atovaquone.
Testosterone The metabolism of Testosterone can be decreased when combined with Atovaquone.
Chlorpropamide The metabolism of Chlorpropamide can be decreased when combined with Atovaquone.
Flurbiprofen The metabolism of Flurbiprofen can be decreased when combined with Atovaquone.
Nateglinide The metabolism of Nateglinide can be decreased when combined with Atovaquone.
Zileuton The metabolism of Zileuton can be decreased when combined with Atovaquone.
Etodolac The metabolism of Etodolac can be decreased when combined with Atovaquone.
Clopidogrel The metabolism of Clopidogrel can be decreased when combined with Atovaquone.
Mefenamic acid The metabolism of Mefenamic acid can be decreased when combined with Atovaquone.
Naproxen The metabolism of Naproxen can be decreased when combined with Atovaquone.
Candesartan cilexetil The metabolism of Candesartan cilexetil can be decreased when combined with Atovaquone.
Phenylbutazone The metabolism of Phenylbutazone can be decreased when combined with Atovaquone.
Meloxicam The risk or severity of methemoglobinemia can be increased when Atovaquone is combined with Meloxicam.
Propofol The metabolism of Propofol can be decreased when combined with Atovaquone.
Tolazamide The metabolism of Tolazamide can be decreased when combined with Atovaquone.
Donepezil The metabolism of Donepezil can be decreased when combined with Atovaquone.
Terbinafine The metabolism of Terbinafine can be decreased when combined with Atovaquone.
Ondansetron The metabolism of Ondansetron can be decreased when combined with Atovaquone.
Buprenorphine The metabolism of Buprenorphine can be decreased when combined with Atovaquone.
Salicylic acid The metabolism of Salicylic acid can be decreased when combined with Atovaquone.
Acetylsalicylic acid The metabolism of Acetylsalicylic acid can be decreased when combined with Atovaquone.
Alosetron The metabolism of Alosetron can be decreased when combined with Atovaquone.
Azelastine The metabolism of Azelastine can be decreased when combined with Atovaquone.
Ramelteon The metabolism of Ramelteon can be decreased when combined with Atovaquone.
Formoterol The metabolism of Formoterol can be decreased when combined with Atovaquone.

Target Protein

Cytochrome b MT-CYB
Dihydroorotate dehydrogenase (quinone), mitochondrial
Dihydroorotate dehydrogenase (quinone), mitochondrial DHODH

Referensi & Sumber

Belum ada data referensi/link/attachment untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field referensi.

Contoh Produk & Brand

Produk: 74 • International brands: 2
Produk
  • Apo-atovaquone
    Suspension • 750 mg / 5 mL • Oral • Canada • Generic • Approved
  • Atovaquone
    Suspension • 750 mg/5mL • Oral • US • Generic • Approved
  • Atovaquone
    Suspension • 750 mg/5mL • Oral • US • Generic • Approved
  • Atovaquone
    Suspension • 750 mg/5mL • Oral • US • Generic • Approved
  • Atovaquone
    Suspension • 750 mg/5mL • Oral • US • Generic • Approved
  • Atovaquone
    Suspension • 750 mg/5mL • Oral • US • Generic • Approved
  • Atovaquone
    Suspension • 750 mg/5mL • Oral • US • Generic • Approved
  • Atovaquone
    Suspension • 750 mg/5mL • Oral • US • Generic • Approved
Menampilkan 8 dari 74 produk.
International Brands
  • Acuvel
  • Wellvone

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul